These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 21560181)

  • 21. Oncolytic Virotherapy in Glioma Tumors.
    Rius-Rocabert S; García-Romero N; García A; Ayuso-Sacido A; Nistal-Villan E
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Oncolytic viruses as a new way of treatment of neoplastic diseases].
    Kukla U; Chronowska J; Łabuzek K; Okopień B
    Pol Merkur Lekarski; 2015 Aug; 39(230):116-21. PubMed ID: 26319388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic Modification of Oncolytic Newcastle Disease Virus for Cancer Therapy.
    Cheng X; Wang W; Xu Q; Harper J; Carroll D; Galinski MS; Suzich J; Jin H
    J Virol; 2016 Jun; 90(11):5343-5352. PubMed ID: 27009956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What is oncolytic virotherapy?
    Cockle JV; Scott KJ
    Arch Dis Child Educ Pract Ed; 2018 Feb; 103(1):43-45. PubMed ID: 28588023
    [No Abstract]   [Full Text] [Related]  

  • 25. Virotherapy: Current Trends and Future Prospects for Treatment of Colon and Rectal Malignancies.
    Lee CL; Veeramani S; Molouki A; Lim SHE; Thomas W; Chia SL; Yusoff K
    Cancer Invest; 2019; 37(8):393-414. PubMed ID: 31502477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Oncolytic viruses for therapy of malignant glioma].
    Sosnovtceva AO; Grinenko NF; Lipatova AV; Chumakov PM; Chekhonin VP
    Biomed Khim; 2016 May; 62(4):376-90. PubMed ID: 27562991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of control theory in a delayed-infection and immune-evading oncolytic virotherapy.
    Lee T; Jenner AL; Kim PS; Lee J
    Math Biosci Eng; 2020 Feb; 17(3):2361-2383. PubMed ID: 32233540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent advances in oncolytic virus-based cancer therapy.
    Fu LQ; Wang SB; Cai MH; Wang XJ; Chen JY; Tong XM; Chen XY; Mou XZ
    Virus Res; 2019 Sep; 270():197675. PubMed ID: 31351879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic potential of oncolytic measles virus: promises and challenges.
    Galanis E
    Clin Pharmacol Ther; 2010 Nov; 88(5):620-5. PubMed ID: 20881957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oncolytic viruses in cancer therapy.
    Vähä-Koskela MJ; Heikkilä JE; Hinkkanen AE
    Cancer Lett; 2007 Sep; 254(2):178-216. PubMed ID: 17383089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of genetically modified Maraba virus as an oncolytic rhabdovirus.
    Brun J; McManus D; Lefebvre C; Hu K; Falls T; Atkins H; Bell JC; McCart JA; Mahoney D; Stojdl DF
    Mol Ther; 2010 Aug; 18(8):1440-9. PubMed ID: 20551913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of Genetically RGD σ1-Modified Oncolytic Reovirus That Enhances JAM-A-Independent Infection of Tumor Cells.
    Kawagishi T; Kanai Y; Nouda R; Fukui I; Nurdin JA; Matsuura Y; Kobayashi T
    J Virol; 2020 Nov; 94(23):. PubMed ID: 32907973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Oncolytic adenoviruses in anti-cancer therapy: current status and perspectives].
    Sviatchenko VA; Tarasova MV; Netesov SV; Chumakov PM
    Mol Biol (Mosk); 2012; 46(4):556-69. PubMed ID: 23113343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oncolytic virotherapy for oral squamous cell carcinoma using replication-competent viruses.
    Saito K; Shirasawa H; Isegawa N; Shiiba M; Uzawa K; Tanzawa H
    Oral Oncol; 2009 Dec; 45(12):1021-7. PubMed ID: 19833547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. To replicate or not to replicate: achieving selective oncolytic virus replication in cancer cells through translational control.
    Mohr I
    Oncogene; 2005 Nov; 24(52):7697-709. PubMed ID: 16299530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fighting Cancer with Viruses: Oncolytic Virus Therapy in China.
    Wei D; Xu J; Liu XY; Chen ZN; Bian H
    Hum Gene Ther; 2018 Feb; 29(2):151-159. PubMed ID: 29284308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent advances of oncolytic virus in cancer therapy.
    Mondal M; Guo J; He P; Zhou D
    Hum Vaccin Immunother; 2020 Oct; 16(10):2389-2402. PubMed ID: 32078405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Oncolytic virus therapy for malignant brain tumors].
    Ino Y; Todo T
    Brain Nerve; 2009 Jul; 61(7):815-22. PubMed ID: 19618859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural and genetically engineered viral agents for oncolysis and gene therapy of human cancers.
    Sinkovics JG; Horvath JC
    Arch Immunol Ther Exp (Warsz); 2008 Dec; 56 Suppl 1():3s-59s. PubMed ID: 19104757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune recruitment and therapeutic synergy: keys to optimizing oncolytic viral therapy?
    Naik JD; Twelves CJ; Selby PJ; Vile RG; Chester JD
    Clin Cancer Res; 2011 Jul; 17(13):4214-24. PubMed ID: 21576084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.